Preparation of product licence applications for veterinary medicines requires metabolic studies in the target species. This experimental procedure uses animals and is costly. In the present report of preliminary studies it is demonstrated that pig liver homogenates prepared from abattoir material and homogenates of rat liver show the interspecies metabolic differences that would be expected in vivo. The results therefore support the use of abattoir-derived liver homogenates in preliminary studies to investigate target species metabolism in veterinary drug development.
Get full access to this article
View all access options for this article.
References
1.
Uchino H., Inaba T. & Kalow W.Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group. Xenobiotica1983; 13: 155-62.
2.
Witkamp R.Oxidative drug metabolism in ruminants and laboratory species. Doctoral Thesis, Utrecht University, The Netherlands 1992 p.42.
3.
McManus ME & Ilett KFComparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species. Xenobiotica1979 ; 9: 107-18.
4.
De Vries JX, Staiger C., Wang NS, Schlicht F. & Koroknay B.Simultaneous determination of antipyrine and metabolites in human plasma and urine by high performance liquid chromatography. Journal of Chromatography and Biomedical Applications1984; 309: 219-21.
5.
Osselton MD, Shaw IC & Stevens HMEnzymic digestion of liver tissue to release barbiturates, salicylic acid and other acidic compounds in cases of human poisoning. Analyst1979; 103: 1160-4.
6.
Van den Broek JM, Wolde-Kraamwinkel HC, Kleinbloesem CH & Breimer DDEffect of rifampicin treatment on in vitro drug metabolising activities in the pig. Biochemical Pharmacology1984; 33: 325-7.
7.
Danhof M., Krom DP & Breimer DDStudies on the different metabolic pathways of antipyrine in rats. Xenobiotica1979; 9: 695-702.
